The Office of Outcomes Research and Evaluation (OORE) is a targeted research and service facility operating under the administrative umbrella of the College of Pharmacy. Established in 2001 with major contractual funding from the Louisiana Department of Health and Hospitals, OORE staffs provide assistance for the critical drug-related component of the Louisiana Medicaid Program.
Our Mission:
As a diverse group of professionals in the ULM family, our mission is to promote improved patient health outcomes through the innovative and efficient application of evidence-based clinical knowledge and data-driven solutions.
 |
 |
 |
The Outcomes Research Section of the Office of Outcomes Research and Evaluation was established in 2002 through a contract with the Louisiana Department of Health and Hospitals. Working with other faculty members in both the College of Health Sciences and the College of Pharmacy, the research staffs assist the Louisiana Medicaid Pharmacy Program by:
- Coordinating the publishing of provider and recipient disease management publications in six key therapeutic areas with a focus on pharmacy care.
- Serving as a consultant to the Louisiana Medicaid Peer-Based Profiling Program.
- Serving as a consultant to the Louisiana Medicaid Pharmacy DUR Board.
- Conducing cost of illness studies, pharmacoeconomic analyses, quality of care studies, policy and program impact studies and other utilization reports as requested.
For further information regarding the Research section, please contact:
Sandra Blake, Ph.D.Director, Outcomes Research Area
Phone: 318-410-4359
Email: blake@ulm.edu
The 2001 Louisiana Legislature's Joint Committee on Health and Welfare passed House Bill 1596/Senate Bill 502 allowing the Department of Health and Hospitals (DHH) to establish a pharmacy prior authorization (PA) process with a preferred drug list (PDL) for certain drugs covered under the Medicaid Pharmacy Benefits Program.
With the implementation of the PA process, drugs are considered "preferred" or "non-preferred". Non-preferred drugs require PA as a condition for payment by the program. Drugs in these therapeutic classes that are not included on the PDL require PA and prescribing practitioners must obtain PA by contacting the Prior Authorization Unit.
The ULM College of Pharmacy operates the Prior Authorization Unit. The PA program began on June 10, 2002 with only two therapeutic classes on the PDL. Since that time, the PDL has been expanded to include more then 40 therapeutic classes. The PA unit handles between 600-900 calls daily, and is staffed by 14 licensed pharmacists. These pharmacists come from a variety of practice settings, including retail, hospital, and consulting, and have over two hundred years combined experience.
For further information regarding the Prior Authorization section, please contact:
Melissa DearDirector, Prior Authorization Unit
Phone: 318-410-4360
Email: dear@ulm.edu